Skip to content
TrustList
1843 Capital logo
Venture capital firm

1843 Capital

Early-stage venture investor in AgeTech and longevity, fintech and cybersecurity companies

1843 Capital cover

About 1843 Capital

1843 Capital is an early-stage venture firm with offices in Washington, DC and New York. Its main theme is AgeTech and longevity, built on the view that the growing number of older Americans is an under-served market. It also invests in fintech and cybersecurity.

Products and services

  • Capital: early-stage investment in founders.
  • Counsel: advice from partners with backgrounds in investing, marketing and operations.
  • Connectivity: introductions that help portfolio companies grow.

Who it serves

Founders in AgeTech and longevity, fintech and cybersecurity. Named portfolio companies include Custodia Bank and Midi Health. The firm says its team has more than 100 years of combined experience.

Key facts

  • Based in: Washington, DC and New York, NY
  • Focus areas: AgeTech, longevity, fintech, cybersecurity
  • Stage: early-stage

Profile written by TrustList from the business's own published information, Oct 2026.

Ask TrustList to introduce you to 1843 Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of 1843 Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about 1843 Capital.

1843 Capital alternatives

Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Venture capital firm partnering with founders from first idea through to public listing

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Munich biopharma company developing drug programmes and licensing them to pharmaceutical partners